Tranexamic Acid In Sodium Chloride Injection, Solution
Product Images NDC 68083-613

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid In Sodium Chloride (NDC 68083-613). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Tranaxemic-spl-bag-label (Tranaxemic Spl Bag Label)

Tranaxemic-spl-bag-label (Tranaxemic Spl Bag Label)
This text provides information about a Tranexamic Acid in 0.7% Sodium Chloride Injection solution. It contains details on dosage, administration, cautions, storage conditions, and manufacturing information. The solution is intended for intravenous infusion only and each mL contains 10 mg of Tranexamic Acid USP and 7 mg of Sodium Chloride USP. It is crucial to check for any particulate matter in the solution before use. The solution should be stored between 20°C to 25°C with permitted excursions to 15°C to 30°C. The bag and port are not made with natural rubber latex, PVC, or DEHP.*
FDA Label Image

Tranaxemic-spl-carton-label (Tranaxemic Spl Carton Label)

Tranaxemic-spl-carton-label (Tranaxemic Spl Carton Label)
This is a description of a pharmaceutical product in the form of single-dose containers containing Tranexamic Acid in 0.7% Sodium Chloride Injection. Each mL of the solution contains 10 mg of Tranexamic Acid and 7 mg of Sodium Chloride. It is intended for intravenous infusion only and should be discarded if not used entirely. The product should be stored at temperatures between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). It is manufactured by GLAND PHARMA LIMITED in India and is sterile, unpreserved, and nonpyrogenic. The dosing and administration information should be followed as per the prescribing information provided.*
FDA Label Image

Tranaxemic-spl-pouch-label (Tranaxemic Spl Pouch Label)

Tranaxemic-spl-pouch-label (Tranaxemic Spl Pouch Label)
This is a description of a pharmaceutical product called Tranexamic Acid in 0.7% Sodium Chloride Injection, presented in a 100 mL Single-Dose Container. Each mL contains 10 mg of Tranexamic Acid USP and 7 mg of Sodium Chloride USP. The solution is for intravenous infusion only. It is important to check for leaks before use and ensure the solution is clear. Additional medications should not be added, and connections must not be used for insertion. The recommended storage temperature is between 20°C to 25°C, with excursions permitted to 15°C to 30°C. This product is sterile, unpreserved, and nonpyrogenic. It is essential to refer to the prescribing information for complete dosing and administration details.*
FDA Label Image

Tranexamic-spl-structure.jpg (Tranexamic Spl Structure)

Tranexamic-spl-structure.jpg (Tranexamic Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.